5Hickey DK, Patel MV, Fahey JV, et al. Innate and adap- tive immunity at mucosal surfaces of the female reproductive tract stratification and integration of immune protection a- gainst the transmission of sexually transmitted infection. J Reprod Immunol, 2011, 88: 185- 194.
6Wira CR, Fahey JV, Ghosh M, et al. Sex hormone regula- tion of innate immunity in the female reproductive tract: the role of epithelial cells in balancing reproductive potential with protection against sexually transmitted pathogens. Am J Re-prod Immunol, 2010, 63: 544- 565.
7Okada H, Okamoto R, Tsuzuki T, et al. Progestins inhibit estradio lindueed vascular endothelial growth factor and stro- mal cell derived factor 1 in human endometrial stromal cells. Fertil Steril, 2011, 96: 786 - 791.
8Winuthayanon W, Hewitt SC, Orvis GD, et al. Uterine epithelial estrogen receptor a is dispensable for proliferation but essential for complete biological and biochemical respon- ses. Proc Natl Acad Sci USA, 2010, 107: 19272- 19277.
9Gortzak- Uzan L, Jimenez W, Nofech - Mozes S, et al. Sentinel lymph node biopsy vs. pelvic lymphadenectomy in early stage cervical cancer: is it time to change the gold standard? Gynecol Oncol, 2010, 116: 28-32.
10Silva CS, Michelin MA, Etchebehere MR, et al. Local lym- phocytes and nitric oxide synthase in the uterine cervical stro- ma of patients with grade Ⅲ cervical intraepithelial neoplasia. Clinics (SaoPaulo), 2010, 65: 575-581.
5Spieqelberq HL, Beck L, Kocher HP, et al. Role of interleukin-4 in human immunoglobulin E formation in hu- PBL-SCID mice [ J ] . J Clin Invest, 1994, 93(2): 711-717.
6Kawano Y, Noma T, Kou K, et al. Regulation of human IgG subclass production by cytokines: human IgG subclass production enhanced differentially by interleukin-6[J]. J Immunol, 1995, 84(2): 278-284.
7Moscicki AB, Schiffman M, Kjaer S, et al. Chapter5: Updating the natural history of HPV and anogenital cancer[J]. Vaccine, 2006, 24(Suppl 3): 42-51.
8Burd EM. Human papillomavirus and cervical cancer[J].Clin Microbiol Rev, 2003, 16: 1-17.
9Hwang TS, J eong JK, Park M, et al. Detection and typing of HPV genotypes in various cervical lesions by HPV oligonucleotide microarray [ J ] . Gynecol Oncol, 2003, 90: 51-56.
10Goncalves MA, Donadi EA. Immune cellular response to HPV: current concepts [J]. Braz J Infect Dis, 2004, 8(1): 1-9.
1Spinillo A,Gardella B,Iacobone AD,et al.Multiple Papillomavirus Infection and Size of Colposcopic Lesions Among Women With Cervical Intraepithelial Neoplasia[J].J Low Genit Tract Dis,2016,20(1):22-25.
2Rositch AF,Soeters HM,Offutt-Powell TN,et al.The incidence of human papillomavirus infection following treatment for cervical neoplasia:a systematic review[J].Gynecol Oncol,2014,132(3):767-779.
3Lucena AA,Guimaraes MV,Michelin MA,et al.Evaluation of T,B and natural killer lymphocyte in the cervical stroma of HIV-positive and negative patients with cervical intraepithelial neoplasia[J].Immunol Lett,2016,169:98-103.
